Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3937-3953

  Swanner, Jessica ^a   Mims, Jade ^a   Carroll, David L ^b   Akman, Steven A ^c   Furdui, Cristina M ^a   Torti, Suzy V ^d   Singh, Ravi N ^a,e  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c Roper St Francis Hospital   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage; Glutathione; Radiation sensitizer; Redox

Indexed keywords

GLUTATHIONE; SILVER NANOPARTICLE; SULFENIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; METAL NANOPARTICLE; RADIOSENSITIZING AGENT; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CANCER INHIBITION; CANCER RADIOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; LUMINAL A BREAST CANCER; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; RADIATION DOSE; RADIOSENSITIZATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR XENOGRAFT; BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; METAL NANOPARTICLES; RADIATION-SENSITIZING AGENTS; SILVER; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84933497061     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S80349     Document Type: Article

References (57)

1. Heath JR, Davis ME. Nanotechnology and cancer. Annu Rev Med. 2008;59:251–265.
2. Chow EKH, Ho D. Cancer nanomedicine: from drug delivery to imaging. Sci Transl Med. 2013;5(216):216rv4.
3. Bhattacharyya S, Kudgus RA, Bhattacharya R, Mukherjee P. Inorganic nanoparticles in cancer therapy. Pharm Res. 2011;28(2):237–259.
4. Chaloupka K, Malam Y, Seifalian AM. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 2010; 28(11):580–588.
5. Gurunathan S, Han JW, Eppakayala V, Jeyaraj M, Kim JH. Cytotoxic-ity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int. 2013;2013:535796.
6. Jeyaraj M, Sathishkumar G, Sivanandhan G, et al. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B Biointerfaces. 2013;106:86–92.
7. Liu JH, Zhao YX, Guo QQ, et al. TAT-modifed nanosilver for combating multidrug-resistant cancer. Biomaterials. 2012;33(26):6155–6161.
8. Locatelli E, Naddaka M, Uboldi C, et al. Targeted delivery of silver nanoparticles and alisertib: in vitro and in vivo synergistic effect against glioblastoma. Nanomedicine (Lond). 2014;9(6):839–849.
9. Sharma S, Chockalingam S, Sanpui P, Chattopadhyay A, Ghosh SS. Silver nanoparticles impregnated alginate-chitosan-blended nanocarrier induces apoptosis in human glioblastoma cells. Adv Healthc Mater. 2014;3(1):106–114.
10. Liu PD, Huang ZH, Chen ZW, et al. Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 2013;5(23):11829–11836.
11. Miura N, Shinohara Y. Cytotoxic effect and apoptosis induction by silver nanoparticles in HeLa cells. Biochem Biophys Res Commun. 2009; 390(3):733–737.
12. Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43(15):6046–6051.
13. Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. Toxicity of silver nanoparticles-Nanoparticle or silver ion? Toxicol Lett. 2012; 208(3):286–292.
14. Guo D, Zhao Y, Zhang Y, et al. The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells. J Biomed Nanotechnol. 2014;10(4):669–678.
15. Guo D, Zhu L, Huang Z, et al. Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials. 2013;34(32):7884–7894.
16. Xu R, Ma J, Sun X, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res. 2009;19(8):1031–1034.
17. Huang P, Yang DP, Zhang C, et al. Protein-directed one-pot synthesis of Ag microspheres with good biocompatibility and enhancement of radiation effects on gastric cancer cells. Nanoscale. 2011;3(9): 3623–3626.
18. Lu R, Yang D, Cui D, Wang Z, Guo L. Egg white-mediated green synthesis of silver nanoparticles with excellent biocompatibility and enhanced radiation effects on cancer cells. Int J Nanomedicine. 2012;7:2101–2107.
19. Braun GB, Friman T, Pang HB, et al. Etchable plasmonic nanopar-ticle probes to image and quantify cellular internalization. Nat Mater. 2014;13(9):904–911.
20. Soenen SJ, Demeester J, De Smedt SC, Braeckmans K. Turning a frown upside down: Exploiting nanoparticle toxicity for anticancer therapy. Nano Today. 2013;8(2):121–125.
21. Arvizo RR, Saha S, Wang EF, Robertson JD, Bhattacharya R, Mukherjee P. Inhibition of tumor growth and metastasis by a self-therapeutic nano-particle. Proc Natl Acad Sci U S A. 2013;110(17):6700–6705.
22. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. The apop-totic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179(3):130–139.
23. Lim HK, Asharani PV, Hande MP. Enhanced genotoxicity of silver nanoparticles in DNA repair defcient Mammalian cells. Front Genet. 2012;3:104.
24. Chen WY, Chang FR, Huang ZY, Chen JH, Wu YC, Wu CC. Tubo-capsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. J Biol Chem. 2008;283(25):17184–17193.
25. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR. Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J. 2009;418:29–37.
26. Seo YH, Carroll KS. Profling protein thiol oxidation in tumor cells using sulfenic acid-specifc antibodies. Proc Natl Acad Sci U S A. 2009;106(38):16163–16168.
27. Pervin S, Tran AH, Zekavati S, Fulknto JM, Singh R, Chaudhuri G. Increased susceptibility of breast cancer cells to stress mediated inhibition of protein synthesis. Cancer Res. 2008;68(12):4862–4874.
28. Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106(8):dju165.
29. Mayer IA, Abramson VG, Lehmann BD, Pietenpol JA. New strategies for triple-negative breast cancer – deciphering the heterogeneity. Clin Cancer Res. 2014;20(4):782–790.
30. Lehmann BD, Pietenpol JA. Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes. J Pathol. 2014;232(2):142–150.
31. Wu JH, Batist G. Glutathione and glutathione analogues; therapeutic potentials. Biochim Biophys Acta. 2013;1830(5):3350–3353.
32. Hamilton D, Batist G. Glutathione analogues in cancer treatment. Curr Oncol Rep. 2004;6(2):116–122.
33. Zhou YT, He WW, Lo YM, Hu XN, Wu XC, Yin JJ. Effect of silver nanomaterials on the activity of thiol-containing antioxidants. J Agric Food Chem. 2013;61(32):7855–7862.
34. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro tox-icity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005; 19(7):975–983.
35. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780–783.
36. Gatti L, Zunino F. Overview of tumor cell chemoresistance mechanisms. Methods Mol Med. 2005;111:127–148.
37. Garbe JC, Bhattacharya S, Merchant B, et al. Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res. 2009;69(19):7557–7568.
38. MacCuspie RI, Allen AJ, Martin MN, Hackley VA. Just add water: reproducible singly dispersed silver nanoparticle suspensions on-demand. J Nanopart Res. 2013;15(7):1760.
39. Pinto VV, Ferreira MJ, Silva R, Santos HA, Silva F, Pereira CM. Long time effect on the stability of silver nanoparticles in aqueous medium: effect of the synthesis and storage conditions. Colloid Surf A. 2010;364(1–3):19–25.
40. de Lima R, Seabra AB, Duran N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012;32(11):867–879.
41. Prat A, Karginova O, Parker JS, et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res Treat. 2013;142(2):237–255.
42. Stampfer MR, Bodnar A, Garbe J, et al. Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell. 1997;8(12):2391–2405.
43. Hammond SL, Ham RG, Stampfer MR. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defned medium and extended serial passage with pituitary extract. Proc Natl Acad Sci U S A. 1984;81(17):5435–5439.
44. Furdui CM, Poole LB. Chemical approaches to detect and analyze protein sulfenic acids. Mass Spectrom Rev. 2014;33(2):126–146.
45. Qian J, Klomsiri C, Wright MW, et al. Simple synthesis of 1, 3-cyclopentanedione derived probes for labeling sulfenic acid proteins. Chem Commun (Camb). 2011;47(32):9203–9205.
46. Lee J, Chatterjee DK, Lee MH, Krishnan S. Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Lett. 2014;347(1): 46–53.
47. Chattopadhyay N, Cai Z, Kwon YL, Lechtman E, Pignol JP, Reilly RM. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat. 2013;137(1):81–91.
48. Mukherjee SG, O’Claonadh N, Casey A, Chambers G. Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In Vitro. 2012;26(2):238–251.
49. Rotblat B, Grunewald TG, Leprivier G, Melino G, Knight RA. Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers. Oncotarget. 2013; 4(12):2577–2590.
50. Verano-Braga T, Miethling-Graff R, Wojdyla K, et al. Insights into the cellular response triggered by silver nanoparticles using quantitative proteomics. ACS Nano. 2014;8(3):2161–2175.
51. Carlson C, Hussain SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608–13619.
52. Ahamed M, Karns M, Goodson M, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharm. 2008;233(3):404–410.
53. Lee KJ, Browning LM, Nallathamby PD, Xu XH. Study of Charge-Dependent Transport and Toxicity of Peptide-Functionalized Silver Nanoparticles Using Zebrafish Embryos and Single Nano-particle Plasmonic Spectroscopy. Chem Res Toxicol. 2013;26(6): 904–917.
54. Newton KM, Puppala HL, Kitchens CL, Colvin VL, Klaine SJ. Silver nanoparticle toxicity to Daphnia magna is a function of dissolved silver concentration. Environ Toxicol Chem. 2013;32(10):2356–2364.
55. Xiu ZM, Zhang QB, Puppala HL, Colvin VL, Alvarez PJ. Negligible Particle-Specifc Antibacterial Activity of Silver Nanoparticles. Nano Lett. 2012;12(8):4271–4275.
56. Toriola AT, Colditz GA. Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat. 2013;138(3):665–673.
57. Boyle P. Triple-negative breast cancer: epidemiological considerations and recommendations. Ann Oncol. 2012;23(Suppl 6):vi7–vi12.